TITLE

6-THIOGUANINE IS WELL TOLERATED AND REASONABLY EFFECTIVE IN CROHN'S DISEASE PATIENTS WHO ARE RESISTANT OR INTOLERANT OF AZATHIOPRINE AND METHOTREXATE

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA104
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The management of patients with Cohen's disease (CD) who have failed to respond or are intolerant to azathioprine and methotrexate remains challenging. Red blood cell 6-thioguaninenucleotide levels correlate with drug efficacy and bone marrow suppression in patients treated with azathioprine. 6-thioguanine forms 6-TON more. In the short term, 6-TG is well tolerated and con be an effective alternative in CD patients who are resistant or intolerant to azathioprine and methotrexate. Recent reports of abnormal liver function with nodular hyperplasia are of concern but were not confirmed in this study over 6 months of treatment.
ACCESSION #
13219221

 

Related Articles

  • Concomitant Use of Immunomodulators with Anti-TNF in Crohn's Disease: Yes or No? Meier, Johannes; Sturm, Andreas // Current Drug Targets;Feb2010, Vol. 11 Issue 2, p176 

    Today up to 40% of Crohn's disease patients receive a concomitant therapy of TNF blockers in combination with thiopurines or methotrexate. Although data of prospective controlled trails are rare, some recently published studies indicate a more rapid onset of remission and increased mucosal...

  • Immunomodulation does not alter histology in resected Crohn’s disease. Frizelle, F. A.; Ing, A.; Gearry, R. B.; Whitehead, M.; Faragher, I. G.; Dobbs, B. // Techniques in Coloproctology;Dec2009, Vol. 13 Issue 4, p295 

    The use of immunomodulators (Azathioprine, 6-Mercaptopurine and Methotrexate) and biological agents (Infliximab and adalimumab) for the treatment of Crohn’s disease (CD) has increased in the recent years with the aim of treating the inflammatory component of the disease and hoping to...

  • Infliximab in Takayasu arteritis: a safe alternative? Karageorgaki, Zaharenia Th.; Mavragani, Clio P.; Papathanasiou, Matthilde A.; Skopouli, Fotini N. // Clinical Rheumatology;Jun2007, Vol. 26 Issue 6, p984 

    To test the efficacy of Infliximab, a chimeric monoclonal antibody against TNF-α, in the treatment of Takayasu arteritis. We used infliximab at an initial dose of 3 mg/kg i.v. at weeks 0, 2, 6, and 8 thereafter in combination with methotrexate or azathioprine, to treat four patients with...

  • Methotrexate effective for maintenance of remission in Crohn's disease. McAvoy, Brian R. // New Zealand Doctor;3/10/2010, p28 

    The article presents a study that examined the effectiveness of methotrexate for maintenance of remission in Crohn's disease.

  • Cytotoxic and Immunologic Effects of Methotrexate in Psoriasis. Weinstein, Gerald D.; Jeffes, Edward; McCullough, Jerry L. // Journal of Investigative Dermatology;Nov90, Vol. 95 Issue 5, p49S 

    Based on recent experience that Cyclosporin A, an immunosuppressive drug, produces marked improvement in psoriasis, possible immunomodulatory activities of methotrexate (MTX) have been reviewed to look for alternate mechanisms of MTX action in psoriasis. It is generally considered that the...

  • Adalimumab.  // Reactions Weekly;7/9/2011, Issue 1359, p6 

    The article describes two cases of women with Crohn's disease who developed mural aortic thrombosis while undergoing adalimumab therapy.

  • Adalimumab.  // Reactions Weekly;7/9/2011, Issue 1359, p6 

    The article describes the case of a 54-year-old woman with Crohn's disease who developed vitiligo while receiving treatment with adalimumab.

  • New pathophysiological insights and modern treatment of IBD. Engel, Matthias A.; Neurath, Markus F. // Journal of Gastroenterology;Jun2010, Vol. 45 Issue 6, p571 

    Inflammatory bowel disease (IBD), which comprises two main types, namely, Crohn’s disease and ulcerative colitis, affects approximately 3.6 million people in the USA and Europe, and an alarming rise in low-incidence areas, such as Asia, is currently being observed. In the last decade,...

  • Methotrexate vs. Cyclosporine for Widespread Psoriasis. Zepf, Bill // American Family Physician;3/1/2004, Vol. 69 Issue 5, p1270 

    Discusses research being done on the safety and efficacy of methotrexate compared with cyclosporine in the treatment of psoriasis. Reference to study V. M. Heydendael, published in the August 14, 2003 issue of the "New England Journal of Medicine"; Clinical administration of methotrexate; Side...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics